Achieve Life Sciences (ACHV)
(Real Time Quote from BATS)
$4.58 USD
-0.03 (-0.65%)
Updated Apr 29, 2024 02:22 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
ACHV 4.58 -0.03(-0.65%)
Will ACHV be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ACHV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for ACHV
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
Achieve Life Sciences files to sell 13.09M shares of common stock for holders
Achieve Life Sciences files to sell 13.09M shares of common stock for holders
Jones starts Achieve Life Sciences at buy, cites market opportunity
Achieve Life Sciences: A Strong Buy for Tobacco Cessation Market Penetration